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Graft-Versus-Host Disease in Fully Allogeneic Small Bowel 
Transplantation: Incidence of the Disease and Strain Combinations 
M. Tanabe, N. Murase, A.J. Demetris, K. Nakamura, T. Furuya, S. Fujisaki, S. Todo, and T.E. Starzl 
WE PREVIOUSLY reported that fully allogeneic 
small bowel transplantation (SB11 from Lewis 
(LEW) to Brown Norway (BN) rats caused fatal graft-
versus-host disease (GVHD) when the recipients were 
treated with a short course of FK 506. 1 Graft-versus-host 
disease has also been well described after parent to F 1 
hybrid SBT,2 in which immune reaction between donor 
and recipient is completely unbalanced. This study was 
carried out to determine if certain strains or combinations 
were more or less susceptible to GVHD, similar to the 
parent to F I hybrid combination. 
MATERIALS AND METHODS 
Animals 
Inbred male LEW (RT·I~, BN (RT-l"), ACI (RT-IQ), and PVG 
(RT-/1 rats, weighing 200 to 300 g, purchased from Harlan 
Sprague-Dawley (Indianapolis, lnd), were used as donors or 
recipients. 
Mixed Lymphocyte Reaction 
One-way mixed lymphocyte reaction (MLR) was performed using 
mesenteric lymph node cells as described before.J Lymphocytes 
from normal LEW, BN, ACI, and PVG rats were used as 
responders and/or stimulators to examine in vivo proliferation 
activity. 
Operation 
Orthotopic SBT with portocaval drainage was performed by 
removing the entire donor small intestine from the ligament of 
Treitz to the ileocecal valve and by anastomosing end-to-side 
between graft aorta and recipient infrarenai aorta and graft porta! 
vein and recipient vena cava. The recipient intestine was removed 
and intestinal continuity was restored by proxima! and distal 
intestinal end-to-end anastomoses. The orthotopic liver transplan-
tation (OLT) was carried out according to Kamada's method! 
Arteria! reconstruction was omitted. Body weight, activity, skin 
color, and defecation were checked daily for the first 14 days, 
foUowed by twice or more per week until day 150. 
Experimental Design 
Six strain combinations, including ACI-LEW, ACI-BN. ACI-
PVG. LEW-BN, LEW-PVG, and BN-PVG were examined. In 
each combination. OLT was performed in both directions. and 
animal survival was compared. Because of the tolerogenic nature 
of the liver graft, some liver grafts were expected to survive 
indefinitely without immunosuppression.5 Any discrepant graft 
and anima! survival between the grafting directions suggests an 
immunologic imbalance between the strain combination. 
SBT with or without immunosuppression was also performed 
for each strain combination in both directions to investigate the 
development of GVHD. For immunosuppression. intramuscular 
FK S06 dissolved in HCO-60 and o-mannitol carrier solvent (gift 
from Fujisawa Pharmaceutical Co. Ltd. Osaka, Japan) was used 
with a daily dose of 0.64 mglkg for 14 days. starting on the day of 
operation. 
Statistical Analysis 
Survival days were analyzed for statistical significance by the 
generalized Wilcoxon test. 
RESULTS 
Mixed Lymphocyte Reaction 
As expected, lymphocytes from all strains used as re-
sponders proliferated more in the presence of allogeneic 
than syngeneic stimulator cells. Proliferative counts in 
recipients who developed GVHO (eg, BN responder and 
LEW stimulator) were not significantly different from 
those of the reversed responder-stimulator direction cases 
(Table I). 
Animal Survival After OL T 
In ACI-BN and ACI-LEW combinations, animal survival 
after OLT was significantly influenced by the direction of 
grafting. In both combinations. ACI liver was acutely 
rejected by BN or LEW recipients with a median survival 
of 10 to 11 days. However. ACI recipients of BN or LEW 
liver grafts survived for more than 90 days. The direction 
of the grafting had less effect on survival in the BN-LEW 
and BN-PVG combinations. The results of PVG-ACI and 
PVG-LEW combinations are still being evaluated, al-
though the direction of grafting did not significantly affect 
survival in these combinations. 
Animal Survival After SST 
In all 12 combinations. untreated recipients died of rejec-
tion (pathologically confirmed) with median survival be· 
tween 5 and 14 days. Untreated BN recipients ofPVG or 
LEW grafts and one PVG recipient with a BN graft 
showed a transient skin rash, which resolved when the 
grafts were rejected. Two-week treatment with FK 506 
effectively prolonged survival for more than 100 days in 
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GVHD IN FULLY ALLOGENEIC SBT 
Table 1. Animal Survival After Orthotopic Uver or Small 
BOMII Tran~i.ntlltlon 
Median Animal Sury'lVal Davs In) 
SeT 
OLTNo 
Donor Recipient Treatment No Treatment FK Treatment 
ACI BN 11 (5)· 8.5(4) 91 (5) 
BN ACI >100 (4) 14 (4) >150 (4) 
ACI LEW 10 (9)· S (4) >111 (3) 
LEW ACI >89.5(4) 8.5 (4) >150 (4) 
LEW BN 30.5 (6)· 12 (3)t 29 (7)* 
BN LEW >100 (6) 10.5 (6) >150 (10) 
PVG BN 25 (3)· 12 (5)t 42 (7)* 
BN PVG >50 (4) 11 (3) >150 (7) 
PVG LEW 30 (3) 13 (3) >150 (4) 
LEW PVG >50 (3) 14 (5) >150 (4) 
ACI PVG >50 (6) 8 (3) >150 (3) 
PVG ACI >50(3) 11 (3) >150 (4) 
'SIraln combinations which show IIgnificantfy different animal SUrvIVal rates 
belWMn It1e directions of InInsplanlabon. 
t Animals whICh died of falal GVHD. 
*Animals showed t8mjX)l8ly GVHD before grail rejecllon. §ene oflhree arumals showed tempot8JY GVHD. 
most of the combinations. except when BN rats were used 
as recipients. ACI grafts transplanted into BN recipients 
developed chronic rejection with median survival of 91 
days. On the other hand. when BN recipients received a 
LEW or PVG graft. the recipients developed a skin rash, 
hyperkeratosis. hair loss. and weight loss after cessation of 
FK 506. and eventually died with median survival of 29 
and 42 days, respectively. 
DISCUSSION 
GVHD after small bowel transplantation has been well 
documented, when immune reaction between the host and 
the recipient was completely unbalanced as seen in unidi-
rectional transplantation from parent to F 1 hybrid strains.2 
In this study. moderate immunologic imbalance was iden-
tified in certain rat strain combinations. such as ACI-BN 
1215 
and ACI-LEW, in which the liver graft was acutely re-
jected. but only in one grafting direction. In the reverse 
order, the graft was accepted. When a small bowel graft 
was used in these relatively unbalanced combinations. 
GVHD was not observed either with or without FK 506 
immunosuppression. In 12 different fully allogeneic small 
bowel transplantations examined here, occurrence of 
GVHD was seen only in BN recipient of LEW or PVG 
grafts under FK 506. Similar fatal GVHD. described by 
DeBruin et al, was also observed in a BN recipient of 
WAG (RT-I") graft under CyA.6 These findings suggest 
that lethal GVHD seen after small bowel transplantation 
under immunosuppression is somewhat unique to the BN 
strain. It is worth noting that the BN strain is also 
susceptible to chronically induced autoimmunity when the 
rats are fed mercuric chloride or golden sodium.7 It may be 
purely coincidental. but the monoclonal antibody, L-21-6. 
which recognizes the invariant chain of the class II MHC 
molecule in rats. reacts with all rat strains tested (LEW, 
ACI, PVG, F334, and WfF) except BN (unpublished 
observation). Since the invariant chain is thought to pro-
tect the class II molecule from endogenous antigen bind-
ing, the difference detected by this antibody may be of 
functional significance. 
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